Streetbeat News

Regulatory

TXG

Torex Gold Resources Inc. has been ordered to temporarily suspend all activities at its Morelos Property due to an inspection following a fatal incident at the El Limón Guajes underground mine.

Portfolio Pulse from

December 10, 2024 | 1:15 am

BIOA

BioAge Labs (BIOA) has announced the discontinuation of its Phase 2 trial for azelaprag, a treatment for metabolic diseases, raising concerns about pre-IPO disclosures.

Portfolio Pulse from

December 10, 2024 | 1:00 am

III

Imperial Metals Corporation and its subsidiary, Mount Polley Mining Corporation, along with Wood Canada Limited, have been charged with alleged violations of the Fisheries Act due to a tailings storage facility failure at Mount Polley Mine in 2014. The charges were filed in the Supreme Court of British Columbia.

Portfolio Pulse from

December 10, 2024 | 1:00 am

PTVE

The Schall Law Firm is investigating Pactiv Evergreen Inc. for potential breaches of fiduciary duty by its directors and management, focusing on securities law violations.

Portfolio Pulse from

December 10, 2024 | 12:45 am

RHHBY

Genentech, part of the Roche Group, presented new data on its bispecific antibody program at the ASH 2024 meeting, highlighting the potential of Columvi and Lunsumio to improve lymphoma treatment outcomes.

Portfolio Pulse from

December 10, 2024 | 12:45 am

DOW

S&P Dow Jones Indices has clarified the float-adjusted liquidity ratio eligibility criteria for the S&P U.S. Indices and Dow Jones U.S. Total Stock Market Indices. This clarification does not result in any changes to the current constituents of these indices.

Portfolio Pulse from

December 09, 2024 | 11:45 pm

EADSF

The U.S. State Department has imposed sanctions on several individuals, including the former CEO of SriLankan Airlines, in connection with Airbus purchases. This move is part of a broader effort to combat corruption and mark International Anti-Corruption Day.

Portfolio Pulse from

December 09, 2024 | 11:00 pm

BITF

Bitfarms has announced a restatement of its previously issued financial statements. This is part of a designated news release related to the company's amended prospectus supplement.

Portfolio Pulse from

December 09, 2024 | 11:00 pm

REGN

Odronextamab shows promising results in treating follicular lymphoma, with complete responses in all patients in the Phase 3 OLYMPIA-1 trial. This highlights its potential in earlier treatment lines and other lymphoma types.

Portfolio Pulse from

December 09, 2024 | 11:00 pm

MTCH

Match Group, Inc. is facing a class action lawsuit for alleged violations of securities regulations. The Schall Law Firm is urging impacted investors to contact them before January 24, 2025.

Portfolio Pulse from

December 09, 2024 | 10:45 pm